Revolutionizing pharmaceutical research and development.
At STAQ Pharma, we are committed to driving innovation in 503B pharmaceutical outsourcing. We take pride every day in ensuring reliable access to essential medications including:
- developing custom medication formulations for specific patient populations
- partnering with healthcare organizations worldwide to address global health concerns
- implementing drug delivery systems to combat drug shortages
Taking guidance from our Product Development Committee, a nationwide group of highly experienced hospital directors and pharmacy leaders, allows us to stay attuned to real-time hospital and patient needs. STAQ Pharma upholds the highest standards of quality and safety in both of our FDA-registered facilities while actively working to address critical medication shortages and continuously improve our offerings.
COVID-19 Nasal Spray
In partnership with IAVI, STAQ Pharma is a providing support services for the production of an innovative intranasal spray targeting COVID-19.
Oncology Development
Compounding cancer-fighting drugs, such as methotrexate, means STAQ Pharma can serve as an onshore supplier for life-saving treatments.
Details coming soon.
Albuterol
One of the most essential medications for pediatric patients, albuterol, began facing a critical shortage in June 2022.
STAQ Pharma has partnered with Children’s Hospital Association to supply and maintain continuous albuterol for children’s hospitals.
Helping Clients with Drug Development and Planning Purposes
SARS-CoV-2 (COVID-19) Infection Blocker Nasal Spray
Angels for Change ProjectPROTECT Partnership
“Innovation is at the heart of everything we do at STAQ Pharma. Our commitment to pioneering advanced pharmaceutical solutions is paramount to meeting the evolving needs of patients and healthcare providers. By integrating real-time insights from experts in the field, we are able to swiftly adapt and develop essential medications that can save patients’ lives.”
Jeff Hval, Chief Pharmacist